{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:26:21Z","timestamp":1785403581962,"version":"3.56.0"},"reference-count":52,"publisher":"Royal College of Psychiatrists","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec id=\"S205647242510968X_as1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Major depressive disorder (MDD) is the leading cause of disability worldwide, affecting roughly 322 million people. Recently, doses of psilocybin have shown promise in treating mood disorders, sparking interest in other dosing practices. According to anecdotal reports and observational studies, microdosing psilocybin yields benefits to mental health; however, rigorously controlled trials have failed to produce compelling evidence for this.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S205647242510968X_as2\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To conduct a phase II, double-blind, placebo-controlled, randomised partial crossover trial to compare microdosing psilocybin to placebo for MDD, evaluating its safety, tolerability and preliminary antidepressant effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S205647242510968X_as3\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Forty adults with MDD will be randomised to four doses of psilocybin (2 mg) or placebo (maltodextrin) once weekly over 4 weeks, then four doses of psilocybin (2 mg) once weekly for an additional 4 weeks. The primary efficacy end-point will be change in depression symptoms, as measured at baseline (0 weeks), after the experimental phase (4 weeks), and after the open-label phase (8 weeks). A battery of mood, well-being, attention, creativity, mindfulness and pro-sociality measures will be administered at each time point. Follow-ups will occur every 6 months for up to 2 years after the trial start date, as part of a long-term extension study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S205647242510968X_as4\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results of the primary outcome of this trial will be published as a manuscript in a peer-reviewed science or medical journal regardless of the magnitude or direction of effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S205647242510968X_as5\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Findings will inform future research on microdosing psilocybin for MDD, regarding dose regimens, effect sizes and expectancy bias. Findings will also facilitate discussions on the comparable benefits of sub- versus threshold doses of psilocybin and the therapeutic value of radically altered perception.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S205647242510968X_as6\">\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov identifier: NCT05259943.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjo.2025.10968","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:05:17Z","timestamp":1771232717000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial"],"prefix":"10.1192","volume":"12","author":[{"given":"Zeina","family":"Beidas","sequence":"first","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"Pneuma Science"},{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Ragnhildstveit","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"Pneuma Science"},{"name":"University of Cambridge"},{"name":"Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Blackman","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"University of Toronto"},{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Anderson","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"University of Toronto"},{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fewster","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"Remedy Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer A.","family":"Syed","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"Pneuma Science"},{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyne","family":"Sobolenko","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail Kaan","family":"Kanca","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Jaglinska","sequence":"additional","affiliation":[{"name":"Pneuma Science"},{"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Son","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"Queen\u2019s University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Farb","sequence":"additional","affiliation":[{"name":"University of Toronto"},{"name":"University of Toronto"},{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-0109","authenticated-orcid":false,"given":"Rotem","family":"Petranker","sequence":"additional","affiliation":[{"name":"Canadian Centre for Psychedelic Science"},{"name":"University of Toronto"},{"id":[{"id":"https:\/\/ror.org\/02fa3aq29","id-type":"ROR","asserted-by":"publisher"}],"name":"McMaster University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"S205647242510968X_ref30","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1933434"},{"key":"S205647242510968X_ref12","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1718250"},{"key":"S205647242510968X_ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063095"},{"key":"S205647242510968X_ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02039-0"},{"key":"S205647242510968X_ref51","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03661-w"},{"key":"S205647242510968X_ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.800072"},{"key":"S205647242510968X_ref20","first-page":"500","article-title":"Microdosing psychedelics: current evidence from controlled studies","volume":"9","author":"Murphy","year":"2024","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"S205647242510968X_ref37","volume-title":"Design and Analysis of Bioavailability and Bioequivalence Studies","author":"Chow","year":"1999"},{"key":"S205647242510968X_ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81446-7"},{"key":"S205647242510968X_ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120908004"},{"key":"S205647242510968X_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2004.07.005"},{"key":"S205647242510968X_ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0308-4"},{"key":"S205647242510968X_ref38","doi-asserted-by":"publisher","DOI":"10.1002\/0470854596"},{"key":"S205647242510968X_ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyz029"},{"key":"S205647242510968X_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05857-0"},{"key":"S205647242510968X_ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119857204"},{"key":"S205647242510968X_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.10.002"},{"key":"S205647242510968X_ref41","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"S205647242510968X_ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5106-2"},{"key":"S205647242510968X_ref13","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1683260"},{"key":"S205647242510968X_ref18","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2021.00155"},{"key":"S205647242510968X_ref42","volume-title":"Columbia-Suicide Severity Rating Scale (C-SSRS)","author":"Posner","year":"2008"},{"key":"S205647242510968X_ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211023"},{"key":"S205647242510968X_ref26","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1593561"},{"key":"S205647242510968X_ref45","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"S205647242510968X_ref49","volume-title":"Structured Clinical Interview for DSM-5 Disorders: SCID-5-CV Clinician Version","author":"First","year":"2016"},{"key":"S205647242510968X_ref52","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"key":"S205647242510968X_ref21","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241278769"},{"key":"S205647242510968X_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.04.013"},{"key":"S205647242510968X_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01866-8"},{"key":"S205647242510968X_ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01811-4"},{"key":"S205647242510968X_ref8","volume-title":"The Psychedelic Explorers Guide: Safe, Therapeutic, and Sacred Journeys","author":"Fadiman","year":"2011"},{"key":"S205647242510968X_ref16","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00192"},{"key":"S205647242510968X_ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1455072517753339"},{"key":"S205647242510968X_ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"S205647242510968X_ref19","first-page":"51073","article-title":"Modern psychedelic microdosing research on mental health: a systematic review","volume":"26","author":"Lo","year":"2024","journal-title":"Prim Care Companion CNS Disord"},{"key":"S205647242510968X_ref32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62878"},{"key":"S205647242510968X_ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.03.006"},{"key":"S205647242510968X_ref46","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-819869-8.00007-0"},{"key":"S205647242510968X_ref6","first-page":"1","article-title":"Legal developments in psychedelic therapeutics","volume":"34","author":"Luong","year":"2022","journal-title":"Health Lawyer"},{"key":"S205647242510968X_ref1","volume-title":"Depression and Other Common Mental Disorders: Global Health Estimates (No. WHO\/MSD\/MER\/2017.2)","year":"2017"},{"key":"S205647242510968X_ref36","doi-asserted-by":"publisher","DOI":"10.1201\/9781420036091"},{"key":"S205647242510968X_ref50","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12931"},{"key":"S205647242510968X_ref34","article-title":"Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity","author":"Cavanna","year":"2021","journal-title":"BioRxiv"},{"key":"S205647242510968X_ref43","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00024"},{"key":"S205647242510968X_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.01.042"},{"key":"S205647242510968X_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.05.048"},{"key":"S205647242510968X_ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1217102"},{"key":"S205647242510968X_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05477-0"},{"key":"S205647242510968X_ref40","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1894"},{"key":"S205647242510968X_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5049-7"},{"key":"S205647242510968X_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"}],"updated-by":[{"DOI":"10.1192\/bjo.2026.12000","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000}}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S205647242510968X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:05:20Z","timestamp":1771232720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S205647242510968X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["S205647242510968X"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2025.10968","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e65"}}